Financial Year |
March 31 2023 |
Monetary Funds |
31,904,402,000.00 |
Held-for-trading Financial Assets |
18,912,276,000.00 |
Notes Receivable |
241,472,000.00 |
Accounts Receivable |
22,574,417,000.00 |
Advances to Suppliers |
3,109,717,000.00 |
Other Receivables |
3,463,006,000.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
36,927,000.00 |
Inventories |
1,881,429,000.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
441,919,000.00 |
Other Current Assets |
5,759,652,000.00 |
Total Current Assets |
89,372,482,000.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
559,935,000.00 |
Long-term Equity Investment |
7,757,408,000.00 |
Investment Properties |
4,841,251,000.00 |
Fixed Assetes |
44,611,305,000.00 |
Under-construction Projects |
10,497,432,000.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
18,602,644,000.00 |
R&D expenses |
322,303,000.00 |
Goodwill |
9,143,285,000.00 |
Long-Term Deferred and Prepaid Expenses |
2,999,881,000.00 |
Deferred Income Tax Assets |
1,689,011,000.00 |
Other Non-Current Assets |
675,800,000.00 |
Sub-Total of Non-Current Assets |
124,714,157,000.00 |
Total Assets |
214,086,639,000.00 |
Short-Term Loans |
13,921,732,000.00 |
Trading Financial liabilities |
81,612,000.00 |
Notes Payable |
108,063,000.00 |
Accounts Payable |
19,929,837,000.00 |
Accounts Received In Advance |
39,123,000.00 |
Employee Compensation Payable |
4,779,160,000.00 |
Taxes Payable |
2,383,411,000.00 |
Interest Payable |
-- |
Dividend Payable |
182,448,000.00 |
Other payables |
13,088,132,000.00 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
11,309,515,000.00 |
Other Current Liabilities |
3,611,282,000.00 |
Sub-Total of Current Liabilities |
70,652,956,000.00 |
Long-term Loans |
11,100,501,000.00 |
Bonds Payable |
18,660,885,000.00 |
Long-Term Accounts Payable |
184,223,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
56,488,000.00 |
Deferred Income Tax Liabilities |
4,561,090,000.00 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
43,681,826,000.00 |
Total Liabilities |
114,334,782,000.00 |
Paid-In Capital(Or Share Stock) |
4,895,202,000.00 |
Capital Surplus |
44,063,763,000.00 |
Surplus Reserve |
1,010,253,000.00 |
LESS:Treasury Stock |
2,100,313,000.00 |
Undistributed Profits |
35,091,409,000.00 |
Minority Stockholder's Interest |
12,139,006,000.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
87,612,851,000.00 |
Owner's Equity(Stockholder's Equity) |
99,751,857,000.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
214,086,639,000.00 |